Freiman Paul E.

NovaBay Pharmaceuticals, Inc.

Director

Avg. Two Year Performance

83% Avg. Purchase Return 35% Compound

49% Avg. Sale Return 22% Compound

Holdings: 1.78K shares

Last Three Months: 23-Aug-24 -- 22-Nov-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Drug Manufacturers - Other

Drugs

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions